Cargando…
Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study
BACKGROUND: Anemia in patients with cancer who are undergoing active therapy is commonly encountered and may worsen quality of life in these patients. The effect of blood transfusion is often temporary and may be associated with serious adverse events. Erythropoiesis-stimulating agents are not effec...
Autores principales: | Abdel-Razeq, Hikmat, Abbasi, Salah, Saadi, Iyad, Jaber, Rana, Abdelelah, Hazem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770628/ https://www.ncbi.nlm.nih.gov/pubmed/24039403 http://dx.doi.org/10.2147/DDDT.S45674 |
Ejemplares similares
-
Effects of intravenous iron monotherapy for patients with iron deficient anemia undergoing total knee arthroplasty
por: Shin, Kyun-Ho, et al.
Publicado: (2020) -
Treatment of anemia in cancer patients undergoing chemotherapy with
intravenous ferric carboxymaltose without erythropoiesis-stimulating
agents
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020) -
Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy
por: Hedenus, Michael, et al.
Publicado: (2014) -
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020) -
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2018)